Skip to main content
OpenTrials

Clinical trial condition

Demyelinating Autoimmune Diseases, CNS

Explore clinical trials studying Demyelinating Autoimmune Diseases, CNS. Study availability and eligibility vary by location and protocol.

2,728 public trials 404 recruiting studies
Refine in advanced search Browse all conditions

Demyelinating Autoimmune Diseases, CNS trial results

Active, Not Recruiting

A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Ocrelizumab in Participants With Relapsing Multiple Sclerosis and Primary Progressive Multiple Sclerosis

NCT07483450

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +11 more
Locations
  • The First Affiliated Hospital of Nanchang University Nanchang, Jiangxi, China
  • Peking Union Medical College Hospital Beijing, China
  • Peking University First Hospital Beijing, China
  • Beijing Hospital of Ministry of Health Beijing, China
View all 17 locations
View Trial Details
Active, Not Recruiting

A Study of Nasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis Patients

NCT06292923

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +10 more
Locations
  • Yale North Haven, Connecticut, United States
  • Johns Hopkins Baltimore, Maryland, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • University of Massachusetts Worcester, Massachusetts, United States
View Trial Details
Active, Not Recruiting

Concentration of Ofatumumab in the Breast Milk of Lactating Women With Relapsing Forms of Multiple Sclerosis

NCT06444113

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • UCSF San Francisco, California, United States
  • UC Health Neuroscience Ctr Aurora, Colorado, United States
  • Northwestern Medicine Northwestern University Winfield, Illinois, United States
  • Brigham and Womens Hospital Brookline, Massachusetts, United States
View all 15 locations
View Trial Details
Active, Not Recruiting

Efficacy and Safety Study of Ravulizumab IV in Pediatric Participants With NMOSD

NCT05346354

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Cranial Nerve Diseases, +10 more
Locations
  • Research Site Washington D.C., District of Columbia, United States
  • Research Site Miami, Florida, United States
  • Research Site Boston, Massachusetts, United States
  • Research Site Durham, North Carolina, United States
View all 16 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple Sclerosis

NCT04544449

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +10 more
Locations
  • Alabama Neurology Associates Homewood, Alabama, United States
  • Sutter East Bay Medical Foundation Berkeley, California, United States
  • Fullerton Neurology and Headache Center Fullerton, California, United States
  • Palo Alto Medical Foundation Research Center Sunnyvale, California, United States
View all 190 locations
View Trial Details
Active, Not Recruiting

Effects of Ocrevus in Relapsing Multiple Sclerosis

NCT04387734

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • Georgia State University Atlanta, Georgia, United States
  • Multiple Sclerosis Center of Atlanta Atlanta, Georgia, United States
View Trial Details

Related conditions